ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1266

Multivariate Risk Model Shows Different Risk Factors for Myocardial Infarction and Stroke in SLE

Michelle Petri1, Jessica Li2 and Daniel Goldman1, 1Johns Hopkins University School of Medicine, Timonium, MD, 2Johns Hopkins University, Baltimore, MD

Meeting: ACR Convergence 2020

Keywords: Cardiovascular, risk factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Cardiovascular events remain a major cause of morbidity and mortality in SLE. Accelerated atherosclerosis occurs in SLE and many other inflammatory diseases.  In the general population both the Framingham Risk Score and the ACC/AHA Risk Equation combine stroke and myocardial infarction as the outcomes.  The prospective SLE Cardiovascular Risk Equation took the same approach.  The model found that traditional risk factors (age, sex, ethnicity, systolic blood pressure, total cholesterol, smoking, and diabetes mellitus) and SLE-specific risk factors (low C3 and lupus anticoagulant) were independent predictors of a later cardiovascular event (Lupus Sci Med. 2019;6:e000346). In this study, we took a different approach, and examined risk factors separately for myocardial infarction and for stroke.

Methods: SLE was defined by the revised ACR or SLICC classification criteria.  Cardiovascular events were defined as myocardial infarction (MI) or stroke (ACC/AHA definition).  In our cohort of 2,398 patients, 1,029 were African-American and 1,369 Caucasian.  Nineteen were missing a SLE diagnosis date and 9 had missing data on events.  There were 230 strokes and 116 myocardial infarctions.

Results: Table 1 shows the multivariate model of predictors of myocardial infarction and of stroke in SLE. Surprisingly, demographic variables such as age at diagnosis and African-American race were not risk factors. Male gender was a risk factor only for MI. Traditional cardiovascular risk factors were present for both outcomes, but overlapped only for hyperlipidemia and diabetes. Smoking was a risk factor only for MI. Hypertension was a risk factor only for stroke. The lupus-specific risk factors, low C3 and lupus anticoagulant, were only risk factors for stroke.

Conclusion: SLE is different from the general population in the predictive value of traditional cardiovascular risk factors for MI and stroke, with only hyperlipidemia and diabetes being risk factors for both. SLE-specific risk factors, low C3 and lupus anticoagulant, were important only for stroke. Attention to both traditional and SLE-specific risk factors remains paramount to lessen the cardiovascular morbidity of SLE.  It is disappointing, however, that we do not have a clinically available SLE  measure that predicts MI. We must still depend on non-invasive tests such as coronary CT or CT angiogram to identify patients early with atherosclerotic plaque.

Relationships Between Predictors and MI/Stroke Based on a Multivariable Model


Disclosure: M. Petri, Astrazeneca, 2, 5, Exagen, 2, 5, GlaxoSmithKline (GSK), 2, 5, Eli Lilly and Company, 2, 5, AbbVie Inc., 5, Aleon Pharma International, Inc, 5, Amgen, 5, Annenberg Center for Health Sciences,, 5, Blackrock Pharma, 5, Bristol Myers Squibb, 5, Decision Resources, 5, Glenmark Pharmaceuticals, 5, INOVA, 5, IQVIA, 5, Janssen Pharmaceutical, 5, Merck EMD Serono, 5, Novartis, 5, Sanofi Japan, 5, Thermofisher, 5, UCB, 5; J. Li, None; D. Goldman, None.

To cite this abstract in AMA style:

Petri M, Li J, Goldman D. Multivariate Risk Model Shows Different Risk Factors for Myocardial Infarction and Stroke in SLE [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/multivariate-risk-model-shows-different-risk-factors-for-myocardial-infarction-and-stroke-in-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multivariate-risk-model-shows-different-risk-factors-for-myocardial-infarction-and-stroke-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology